Related Experiment Video
Updated: May 2, 2026

07:10
Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
14.1K
Generation of improved humanized mouse models for human infectious diseases
Michael A Brehm1, Michael V Wiles2, Dale L Greiner1
1The University of Massachusetts Medical School, 368 Plantation Street, Worcester, MA 01605, United States.
Journal of Immunological Methods
|March 11, 2014
Summary
Humanized mice, with improved immune systems, are crucial for studying human infectious diseases like HIV-1. Next-generation models enhance research into disease and treatments.
Area of Science:
- Immunology
- Infectious Diseases
- Animal Models
Background:
- Studying human-specific infectious agents requires effective small animal models.
- Immunodeficient mice with human immune system components are vital research tools.
Purpose of the Study:
- To review advancements in humanized mouse models for studying human-specific infectious agents.
- To highlight opportunities for improving these models for preclinical research.
Main Methods:
- Development of immunodeficient mice with mutations in the IL2 receptor common gamma chain gene (IL2rg(null)).
- Engraftment of hematopoietic stem cells, lymphoid cells, and tissues to create human immune systems.
- Implementation of innovative technologies to enhance human cell engraftment and function.
Main Results:
- Humanized mice successfully engraft human immune cells and tissues, enabling study of human pathogens.
- Next-generation models incorporate host modifications, human growth factors, and improved engraftment protocols.
- These advancements accelerate the development of robust models for disease pathogenesis and therapeutic testing.
Conclusions:
- Humanized mouse models are essential for preclinical studies of human infectious diseases, including HIV-1.
- Ongoing technological innovations are crucial for developing superior models.
- Improved models will advance understanding of disease and facilitate the testing of new vaccines and therapies.

